3.0.0 3792 2023-01-11T13:40:39Z 2023-01-11T13:40:39Z Senate S 2018-12-19 115 ssju00 Judiciary Committee Senate Standing Referred to 2018-12-19T22:33:01Z Preserve Access to Affordable Generics Act 115 124 S 2017-01-12 Read twice and referred to the Committee on the Judiciary. Related bill CRS 2018-12-19 ssju00 Judiciary Committee Senate Read twice and referred to the Committee on the Judiciary. IntroReferral 2018-12-19 Introduced in Senate IntroReferral 10000 9 Library of Congress K000367 Sen. Klobuchar, Amy [D-MN] Amy Klobuchar D MN N G000386 Sen. Grassley, Chuck [R-IA] Charles Grassley R IA E. 2018-12-19 True Health Administrative law and regulatory procedures Civil actions and liability Competition and antitrust Contracts and agency Federal Trade Commission (FTC) Intellectual property Judicial review and appeals Licensing and registrations Marketing and advertising Prescription drugs Health 00 2018-12-19 Introduced in Senate 2019-07-11T16:22:24Z Preserve Access to Affordable Generics and Biosimilars Act

This bill amends the Federal Trade Commission Act to authorize the Federal Trade Commission to initiate proceedings against parties to any agreement resolving or settling a patent infringement claim in connection with the sale of a drug or biological product. Such an agreement, with specified exceptions, is presumed to have anticompetitive effects and violates this bill if the filer of an abbreviated new drug (generic) application or a biosimilar biological product application: (1) receives anything of value; and (2) agrees to limit or forego research, development, manufacturing, marketing, or sales of the generic drug or biosimilar biological product for any period of time.

]]> Preserve Access to Affordable Generics and Biosimilars Act Display Title Preserve Access to Affordable Generics and Biosimilars Act Official Title as Introduced A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufactures from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products. Introduced in Senate IS Short Titles as Introduced Preserve Access to Affordable Generics and Biosimilars Act Introduced in Senate 2018-12-19T05:00:00Z https://www.govinfo.gov/content/pkg/BILLS-115s3792is/xml/BILLS-115s3792is.xml 2018-12-19 Read twice and referred to the Committee on the Judiciary. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.